Logal Adam has filed 4 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 437500 shares of OPKO HEALTH, INC. ($OPK) on May 27, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27, 2025 | OPKO HEALTH, INC. | $OPK | Logal Adam | Sr. Vice President, CFO | A | Stock Option (Right to Buy) | 437500 | $0.00 | 437,500.0000 | 998,363,636 | 9999.99% | 0.04% |
| July 24, 2024 | OPKO HEALTH, INC. | $OPK | Logal Adam | Sr. Vice President, CFO | A | Common Stock | 437500 | $0.00 | 616,662.0000 | 0 | 244.19% | 0.00% |
| Dec. 6, 2023 | Xenetic Biosciences, Inc. | $XBIO | Logal Adam | Director | A | Stock Options | 2500 | $0.00 | 2,500.0000 | 0 | 9999.99% | 0.00% |
| May 18, 2023 | OPKO HEALTH, INC. | $OPK | Logal Adam | Sr. Vice President, CFO | A | Stock Option (Right to Buy) | 700000 | $0.00 | 700,000.0000 | 0 | 9999.99% | 0.00% |